Shire
AbbVie spells out Shire benefits
June 26, 2014Sales and Marketing ADHD, AbbVie, Abbott, Humira, Shire, merger
AbbVie has spelt out exactly why it believes that Shire should accept its $46.5 billion bid. The US firm wants …
AbbVie moves in on Shire with $46 billion bid
June 20, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Abbott, AstraZeneca, Pfizer, Shire, merger
AbbVie is looking to acquire Ireland-based speciality biopharma firm Shire in a deal that could shore up the US company’s …
Pharma manufacturing news in brief
February 17, 2014Manufacturing and Production Advaxis, Alexion, Berkshire Sterile Manufacturing, Catalent, Hospira, Shire
Hospira has made significant progress in restoring quality compliance at its facilities in Rocky Mount and Austin, which were the …
Shire chief financial officer steps down
February 17, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, hetherington
Shire’s chief financial officer (CFO) Graham Hetherington has notified the company of his decision to step down. Flemming Ornskov, Shire …
Shire replaces retiring chairman with former banker
January 24, 2014Sales and Marketing Organogenesis, Shire, dermagraft, emmens, kilsby
Susan Kilsby is to be the new chairman at Shire and steps into Matthew Emmens’s role as he retires from …
Shire sheds Dermagraft at $650m loss
January 20, 2014Sales and Marketing Organogenesis, Shire, dermagraft
Shire has offloaded its Dermagraft business to Organogenesis just three years after purchasing the company. Given the sale has come …
Shire spends $4.2 billion on ViroPharma purchase
November 11, 2013Sales and Marketing Cinryze, Firazyr, Shire, Viropharma
Shire has announced a $4.2 billion deal to buy US-based ViroPharma in a pact that is designed to bolster the …
Shire to cut UK research jobs says source
November 7, 2013Research and Development, Sales and Marketing England, Shire, UK, cuts
Rumours are growing that Shire will be cutting dozens of research posts at its R&D centre in Basingstoke, Hampshire. This …
Shire hires finance director
October 28, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, dominic blakemore
Dominic Blakemore will join Shire’s Board from January next year as a non-executive director and member of its Audit, Compliance …
Shire slated following Adderall T-shirt controversy
October 18, 2013Medical Communications, Sales and Marketing Adderall, EMA, FDA, Shire
A senior doctor and patient welfare advocate has criticised Shire after T-shirts emblazoned with the word ‘Adderall’ appeared for sale …
Adderall hits Shire sales
July 30, 2013Sales and Marketing Adderall, Shire, Vyvanse, ldx
Falling sales of Adderall XR have hit Shire in the second quarter of the year, with the ADHD drug dropping …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
